BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10992182)

  • 1. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
    Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
    Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal outcome after in utero exposure to cancer chemotherapy.
    Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
    Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
    Cardonick E; Usmani A; Ghaffar S
    Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
    Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
    Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threatened miscarriage as a predictor of obstetric outcome.
    Johns J; Jauniaux E
    Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
    Bar-Oz B; Clementi M; Di Giantonio E; Greenberg R; Beer M; Merlob P; Arnon J; Ornoy A; Zimmerman DM; Berkovitch M
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):176-9. PubMed ID: 15808375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
    Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
    Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
    Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
    Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
    Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome following in utero exposure to bisphosphonates.
    Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
    Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population.
    El-Kady D; Gilbert WM; Anderson J; Danielsen B; Towner D; Smith LH
    Am J Obstet Gynecol; 2004 Jun; 190(6):1661-8. PubMed ID: 15284764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome in women with prosthetic heart valves.
    Nassar AH; Hobeika EM; Abd Essamad HM; Taher A; Khalil AM; Usta IM
    Am J Obstet Gynecol; 2004 Sep; 191(3):1009-13. PubMed ID: 15467581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical exertion at work and the risk of preterm delivery and small-for-gestational-age birth.
    Pompeii LA; Savitz DA; Evenson KR; Rogers B; McMahon M
    Obstet Gynecol; 2005 Dec; 106(6):1279-88. PubMed ID: 16319253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
    Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
    Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy.
    De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M
    Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome following a second-trimester loss.
    Goldenberg RL; Mayberry SK; Copper RL; Dubard MB; Hauth JC
    Obstet Gynecol; 1993 Mar; 81(3):444-6. PubMed ID: 8437803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
    Colvin J; Bower C; Dickinson JE; Sokol J
    Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
    Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
    Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.